07 July 2020 2 Min Read
GSK joins Philip Morris-backed Medicago on plant-based Covid-19 vaccine
Human testing is due to start in mid-July and, if successful, the companies could manufacture about 100-million doses by the end of 2021
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In